(Q34014099)

30 July 2017

title

Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity (English)

1 reference

30 July 2017

1 reference

Dániel Aradi

1

1 reference

30 July 2017

Orsolya Rideg

2

1 reference

30 July 2017

András Vorobcsuk

3

1 reference

30 July 2017

Tamás Magyarlaki

4

1 reference

30 July 2017

Balázs Magyari

5

1 reference

30 July 2017

Attila Kónyi

6

1 reference

30 July 2017

Tünde Pintér

7

1 reference

30 July 2017

Iván G Horváth

8

1 reference

30 July 2017

András Komócsi

9

1 reference

30 July 2017

publication date

9 September 2011

1 reference

European Journal of Clinical Investigation

30 July 2017

published in

1 reference

30 July 2017

volume

42

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

384-392

1 reference

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Acceptance of high platelet reactivity as a risk factor: now, what do we do about it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Guidelines on myocardial revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Thienopyridine therapy influences late outcome after coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Low platelet disaggregation predicts poor response to 150 mg clopidogrel in patients with elevated platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Can we override clopidogrel resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial dama

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02594.X

10.1111/J.1365-2362.2011.02594.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference